Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proof of Concept Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01801917
What this trial is testing

Efficacy and Tolerability of BAF312 in Patients With Polymyositis

Who this might be right for
Polymyositis
Novartis Pharmaceuticals 14
Post-approval studies (Phase 4)Study completedNCT07534878
What this trial is testing

Health Benefits of Nutraceutical Supplementation in Older Adults.

Who this might be right for
Age-related Functional DeclineMild Cognitive Impairment
GPLIFE HEALTHCARE PRIVATE LIMITED 23
Testing effectiveness (Phase 2)Study completedNCT00943449
What this trial is testing

4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
4SC AG 57
Not applicableTemporarily pausedNCT05888025
What this trial is testing

MBCT-T for Preoperative Pain Catastrophizing and Pain Outcomes After Spine Surgery

Who this might be right for
Pain
NYU Langone Health 25
Testing effectiveness (Phase 2)Study completedNCT02764125
What this trial is testing

Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)

Who this might be right for
Parkinson's Disease
Orion Corporation, Orion Pharma 84
Testing effectiveness (Phase 2)Ended earlyNCT03149549
What this trial is testing

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Who this might be right for
Solid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 99
Not applicableStudy completedNCT04970563
What this trial is testing

Detection of Asymptomatic SARS-Cov2 Infected Patients by Detection Dogs: "Proof of Concept" Study (CoviDetectionDog)-Covid-19

Who this might be right for
Infection by SARS-COV-2Healthy Controls
Hôpital Européen Marseille 160
Testing effectiveness (Phase 2)Looking for participantsNCT07377656
What this trial is testing

Strengthening HPV Immunization Through EPI Leveraged Delivery

Who this might be right for
HPV Vaccine
International Vaccine Institute 115
Testing effectiveness (Phase 2)Study completedNCT04179266
What this trial is testing

Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache

Who this might be right for
Cluster Headache
CCH Pharmaceuticals 23
Testing effectiveness (Phase 2)Looking for participantsNCT03762395
What this trial is testing

Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma

Who this might be right for
AsthmaObesity
University of Colorado, Denver 60
Not applicableActive Not RecruitingNCT05867537
What this trial is testing

Proof of Concept Human Study: Dietary Intervention to Modify Intestinal Inflammation in IBD

Who this might be right for
Reduction of Intestinal Inflammatory Activity
Universitätsklinikum Hamburg-Eppendorf 20
Testing effectiveness (Phase 2)Study completedNCT03053102
What this trial is testing

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Alexion Pharmaceuticals, Inc. 10
Testing effectiveness (Phase 2)WithdrawnNCT06473974
What this trial is testing

Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial Hyperpigmentation

Who this might be right for
Facial Hyperpigmentation
Kayuraeffect, LLP
Testing effectiveness (Phase 2)Study completedNCT03960658
What this trial is testing

Ketamine and Prolonged Exposure in PTSD

Who this might be right for
Post-traumatic Stress Disorder
Minneapolis Veterans Affairs Medical Center 12
Not applicableLooking for participantsNCT06714097
What this trial is testing

Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)

Who this might be right for
StrokeMoyamoya DiseaseCerebral Amyloid Angiopathy
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 20
Early research (Phase 1)Study completedNCT01428297
What this trial is testing

A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome

Who this might be right for
Healthy VolunteersAtopic DermatitisNetherton Syndrome
Novartis Pharmaceuticals 12
Not applicableStudy completedNCT03676582
What this trial is testing

AspiRATE: Novel Intervention to Acoustically Detect Silent Aspiration in Acquired Dysphagia.

Who this might be right for
Dysphagia, Oropharyngeal
Sheffield Teaching Hospitals NHS Foundation Trust 25
Testing effectiveness (Phase 2)Study completedNCT01449591
What this trial is testing

Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients

Who this might be right for
Erythemato-telangiectatic Rosacea
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Ended earlyNCT00095576
What this trial is testing

Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)

Who this might be right for
AIDSHIV Infections
Merck Sharp & Dohme LLC 3,000
Not applicableLooking for participantsNCT05908760
What this trial is testing

CO2 Rebreathing in nOH: A Proof-of-Concept Pilot Study

Who this might be right for
Neurogenic Orthostatic HypotensionAutonomic Failure
University of Calgary 28
Next Page